A European box of Pfizer's pneumococcal vaccine. Photo: Fred Tanneau/AFP via Getty Images

In a narrow 8-6 vote today, a federal vaccine advisory panel shot down its 2014 recommendation that all adults 65 and older get a pneumococcal vaccine called Prevnar 13. Instead, the panel said seniors should get the vaccine based on conversations with their clinicians.

Why it matters: Seniors can still get the shot, but the vaccine won't be universally recommended — to the dismay of the vaccine makers. Pfizer sells Prevnar 13, and the drug company's stock shot down 2% once investors learned of the vote.

Details: Several members of the Advisory Committee on Immunization Practices, part of the Centers for Disease Control and Prevention, said this vote was one of the most difficult they've encountered.

  • The current evidence, presented during today's meeting, shows the vaccine only had marginal benefits for adults 65 and older.
  • However, Prevnar 13 is still universally recommended for children younger than 2.

What they're saying: Because more children are taking the vaccine and fewer are getting sick with pneumococcus, fewer older adults are getting exposed and sick, the experts said.

  • Supplying Prevnar 13 for adults "is not where the public health bang for the buck is," and "we're diluting the message that vaccinating the children is important," said Paul Hunter, a committee member and public health official in Milwaukee who voted against the 2014 recommendation.

1 money thing: Prevnar 13 is Pfizer's best-selling drug. U.S. sales exploded in 2015 after the CDC's recommendation, and although insurance will still cover the pricey vaccine, sales would drop if fewer adults feel like they need to get it.

Go deeper

Doomsday has arrived for tens of thousands of workers

Illustration: Sarah Grillo/Axios

Federal coronavirus aid for airlines expires on Thursday with no renewal in sight, meaning massive layoffs for the industry aren't far behind.

The big picture: Airline workers aren't alone on the unemployment line. Oil companies, tire manufacturers, book publishers and insurers are among those that have announced tens of thousands of layoffs. Federal aid through the CARES Act earlier this year delayed most layoffs — until now.

3 hours ago - Science

How the brain handles the unknown

Illustration: Sarah Grillo/Axios

Uncertainty can be hard for humans. It drives anxiety, an emotion neuroscientists are trying to understand and psychologists are trying to better treat.

Why it matters: Under the threat of a virus, job insecurity, election uncertainty, and a general pandemic life-in-limbo that is upending school, holidays and more, people are especially anxious.

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 3 p.m. ET: 34,103,279 — Total deaths: 1,016,167 — Total recoveries: 23,694,869Map.
  2. U.S.: Total confirmed cases as of 3 p.m. ET: 7,255,546 — Total deaths: 207,374 — Total recoveries: 2,840,688 — Total tests: 103,939,667Map.
  3. Politics: House prepares to pass revised COVID relief bill as White House talks hit roadblock.
  4. Health: Health officials urge flu shots, warning of "twindemic" with COVID-19 — Coronavirus infections rise in 25 states.
  5. Business: Remdesivir is good business for Gilead.